TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Aditxt ( (ADTX) ) is now available.
On November 18, 2025, Aditxt, Inc. announced its strategic evolution under the bitXbio™ strategy, which aims to connect public markets, blockchain, Web3, and digital assets to advance health innovations. The company filed a preliminary proxy statement with the SEC for a special stockholders meeting to approve proposals including an Employee Stock Purchase Plan and a name change to ‘bitXbio, Inc.’ This transition is expected to enhance Aditxt’s platform as a globally participatory life sciences entity. Additionally, Aditxt’s subsidiary Pearsanta plans an IPO in 2026, and Evofem is focusing on regaining a national exchange listing, both pivotal to Aditxt’s 2026 growth strategy.
More about Aditxt
Aditxt, Inc. is a social innovation platform that accelerates promising health innovations. The company operates through an ecosystem of research institutions, industry partners, and shareholders, focusing on autoimmunity, cancer and early disease detection, infectious diseases, and women’s health. Aditxt aims to democratize innovation and empower collective progress through its unique model.
Average Trading Volume: 84,168
Technical Sentiment Signal: Strong Sell
Current Market Cap: $2.43M
Learn more about ADTX stock on TipRanks’ Stock Analysis page.